COVID-19 Vaccine May Help Mesothelioma Survivors Avoid Serious Side Effects
Several new studies illustrate the importance of the COVID-19 vaccine for malignant mesothelioma patients and survivors. They suggest that people…
Biopsy | Diagnosis | Europe | International | Symptoms | Treatments
Medical Thoracoscopy Safe and Effective for Mesothelioma Diagnosis
UK researchers say a minimally invasive procedure called medical thoracoscopy is safe and effective for diagnosing mesothelioma and treating its…
Europe | Immune Systems | International | New Drugs | Research | Treatments
ONCOS-102 Gets Fast Track Designation for Mesothelioma Treatment
An immunotherapy treatment called ONCOS-102 has received fast track designation from the FDA as a pleural mesothelioma therapy. Targovax is…
Europe | International | New Studies | Prognosis | Research
Radiotherapy Outcomes in Mesothelioma Linked to Metabolism
Italian researchers say metabolic markers may hold the key to predicting radiotherapy outcomes in people with mesothelioma. Metabolism is the…
Biomarkers | Diagnosis | New Studies | Prognosis | Research
Standard Biomarkers for Pleural Mesothelioma “Not Useful” for Immunotherapy
Two of the most important biomarkers for pleural mesothelioma are not much help when it comes to tracking response to…
Chemotherapy | Europe | Genetics | International | Research | Treatments
Chemoresistance in Mesothelioma: The Role of Genetics
A team of Swiss and German researchers have a theory about why so many mesothelioma patients experience chemoresistance. Chemotherapy is…
Diabetes Drug Triggers Mesothelioma Cell Death in New Study
A new study suggests that the diabetes drug metformin may help keep mesothelioma cells from growing and spreading. The study…
Opdivo as Second-Line Treatment Option for Mesothelioma: Promising New Data
A new study suggests that the cancer drug Opdivo could be an effective second-line treatment option for people with relapsed…
Maintenance Therapy with Gemcitabine Extends Mesothelioma Survival in Dutch Study
Dutch researchers say administering maintenance therapy with gemcitabine after chemotherapy may help mesothelioma patients live longer than supportive care alone. …
Epithelioid Subtype Leads to Longer Survival Regardless of Treatment
Danish researchers say people with the epithelioid subtype of pleural mesothelioma tend to live longer than those with other subtypes,…